Join to View Full Profile
600 N Wolfe StBaltimore, MD 21287
Phone+1 410-955-8964
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Powell, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is an Associate Professor at Johns Hopkins University School of Medicine.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1998
Johns Hopkins UniversityResidency, Internal Medicine, 1992 - 1995
Emory University School of MedicineClass of 1992
Certifications & Licensure
MD State Medical License 1996 - 2025
Publications & Presentations
PubMed
- 1 citationsDistinct myeloid-derived suppressor cell populations in human glioblastoma.Christina Jackson, Christopher Cherry, Sadhana Bom, Arbor G Dykema, Rulin Wang
Science. 2025-01-17 - 6 citationsMetabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers.Monali Praharaj, Fan Shen, Alex J Lee, Liang Zhao, Thomas R Nirschl
Cancer Immunology Research. 2024-07-02 - Adoptive transfer of CD49aTissue resident memory cells reverses pulmonary fibrosis in mice.Samuel L Collins, Yee Chan-Li, Kevin Shenderov, Astrid Gillich, Andrew M Nelson
Biorxiv. 2024-03-14
Press Mentions
MMI Assistant Professor Elizabeth Thompson Studies Human Immunology, Vaccination, and InfectionMarch 10th, 2025
GSK-Backed Biotech Gets $50M Upfront in Autoimmune Disease Deal with LillyMarch 31st, 2020- Another Immunometabolism Deal? Johns Hopkins Spinout Dracen Lands $36M Investment from DeerfieldMarch 22nd, 2018
- Join now to see all
